EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recognised as the largest modifiable risk factor for dementia....
Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership
SILICON VALLEY, Calif., June 27, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world's most critical challenges. This recognition celebrates enterprises that have successfully aligned innovation, sustainable growth,...
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Ltd. (Vcare PharmaTech), has been officially accepted by the NMPA. The drug has now entered the NDA stage. As a global pioneer in novel antiplatelet agents, Sumecigrel is expected to provide...
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
NYSE Content Update: Doncasters Shares Jump 42% in NYSE Trading Debut
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 26, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" ...
Merz Aesthetics Launches Ultherapy Mask – PDRN Peptide Radiance in Malaysia and Appoints Scha Alyahya as the First Ultherapy PRIME Brand Ambassador
Ultherapy Mask - PDRN Peptide Radiance now available in Malaysia exclusively through PRIME certified clinics The at-home mask is designed to support hydration, skin recovery, and overall radiance after Ultherapy PRIME treatment Scha Alyahya named Malaysia's first Ultherapy PRIME Brand Ambassador, championing authentic and personalized aesthetic care KUALA...
Beyond Injections: S-CELL Unveils Breakthrough “Endogenous GLP-1” Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology
HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight management, and focuses on naturally stimulating the body's own production of GLP-1 (Glucagon-like peptide-1). The gut microbiome is...
State Grid Anding District Power Supply Company (Dingxi City): Power Safeguards a New Medical Hub
DINGXI, China, June 26, 2026 /PRNewswire/ -- On June 23, State Grid Gansu Dingxi Anding District Power Supply Company successfully completed the acceptance and power transmission of the power receiving project for the Xichuan New Campus of Dingxi Hospital Affiliated to Changchun University of Chinese Medicine. The company provided safe and reliable power supply support to ensure the commissioning...
Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia
SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that China's National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL® (lerodalcibep), a third-generation PCSK9 inhibitor, for subcutaneous use as an adjunct to...
Dr.Look Ai helps families cut kids’ passive screen time
Two-Time International Design Award Winner Dr.Look Ai Donates AI Learning Cameras to Two Children's Hospitals, Tackling North American Parenting Challenges Through Real-World Exploration BOSTON, June 26, 2026 /PRNewswire/ -- Dr.Look Ai, a children's technology brand and two-time international design award winner, has donated its AI Learning Cameras to two leading children's hospitals in Boston and Seattle, addressing pressing...
